C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
09/2011
09/07/2011	EP2362782A1 A vaccinia virus protein a46 peptide and use thereof
09/07/2011	EP2003967B1 Use of somatostatin agonists to treat medullary thyroid carcinoma
09/07/2011	CN102177173A Collagen peptide, dipeptide, and agent for prevention of disease
09/07/2011	CN102174530A Biosynthetic gene cluster of cyclic peptides YM-216391
09/07/2011	CN102174077A Oligopeptide molecules with intramolecular disulfide bonds and application thereof to assisting in protein oxidation renaturation
09/07/2011	CN102174076A Compounds for proteasome enzyme inhibition
09/07/2011	CN102174075A Lipopeptide compound as well as compositions, preparation method and application thereof
09/07/2011	CN102174074A Inhabitors of cancer cell, T-cell and keratinocyte proliferation
09/07/2011	CN101139383B C end modification endomorphin 2
09/06/2011	US8013116 Therapeutic peptides and method
09/06/2011	US8013113 FRET protease assays for clostridial toxins
09/06/2011	US8013112 Compositions comprising human brain natriuretic peptide (BNP) fragments
09/06/2011	US8013014 Aza-peptide epoxides
09/06/2011	US8012934 Small peptides and methods for treatment of inflammation
09/01/2011	WO2011104649A1 Peptide analogues
09/01/2011	WO2011104266A1 Dimeric iap inhibitors
09/01/2011	US20110212903 Metal-binding compounds and uses therefor
09/01/2011	US20110212902 Metal-binding compounds and uses therefor
09/01/2011	US20110212896 Peptides for the treatment of oxidative stress related disorders
09/01/2011	US20110212891 Azepinone derivatives
09/01/2011	US20110212877 Detergent composition
09/01/2011	US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions
09/01/2011	CA2790302A1 Dimeric iap inhibitors
09/01/2011	CA2789606A1 Peptide analogues as opioid receptor agonists
08/2011
08/31/2011	EP2361925A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
08/31/2011	EP1506000B9 Heterocyclicsulfonamide hepatitis c virus inhibitors
08/31/2011	CN102171238A Treatment of biofilms
08/31/2011	CN102170939A Depsipeptides and their therapeutic use
08/31/2011	CN102167727A Synthesis method of pidotimod
08/31/2011	CN102167722A Method for preparing neotame
08/31/2011	CN101768209B Hypotensive peptide with high in-vivo activity and preparation and purification method thereof
08/30/2011	US8008440 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
08/30/2011	US8008437 Prostatic/ovarian tumor antigen for use in diagnosis, prevention and treatment of cell proliferative disorders
08/30/2011	US8008431 Tumor-associated peptides that bind to MHC-molecules
08/30/2011	US8008251 Macrocyclic inhibitors of hepatitis C virus
08/30/2011	CA2251647C Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207672 Methods of treatment using a prodrug of an excitatory amino acid
08/25/2011	US20110207658 High Purity Lipopeptides
08/25/2011	US20110207654 Peptide analogues
08/25/2011	US20110206757 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/25/2011	US20110206704 Methods and compositions for modulating hepatocyte growth factor activator
08/24/2011	EP2360259A2 Promyostatin peptides and methods of using same
08/24/2011	EP2358857A1 Detergent composition
08/24/2011	EP2358737A2 Rgd-containing peptidomimetics and uses thereof
08/24/2011	EP2358736A1 Therapeutic antiviral peptides
08/24/2011	EP2358735A1 Azepinone derivatives
08/24/2011	EP1697411B1 Process for purifying interferon beta
08/24/2011	CN102164946A Angiotensin converting enzyme-inhibiting peptide
08/24/2011	CN102164928A Hepatitis c virus inhibitors
08/24/2011	CN102161656A Caspase inhibitors and uses thereof
08/24/2011	CN102160890A Pharmaceutical composition comprising an analgesic peptide
08/23/2011	US8003791 Boronic ester and acid compounds, synthesis and uses
08/23/2011	US8003758 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
08/23/2011	US8003756 Agent derived from tortoise spleen stimulating mammalian hemopoiesis
08/23/2011	US8003755 Hydrochloride salts of a glycopeptide phosphonate derivative
08/23/2011	US8003753 Fret protease assays for clostridial toxins
08/23/2011	US8003628 Methods of inhibiting osteoclast activity
08/23/2011	US8003608 Using small molecule amino acid derivatives
08/23/2011	US8003108 Sclerostin epitopes
08/23/2011	CA2516018C Hepatitis c inhibitor peptide analogs
08/23/2011	CA2498572C Macrocyclic peptides active against the hepatitis c virus
08/18/2011	WO2011098904A1 Iap bir domain binding compounds
08/18/2011	WO2011098603A1 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
08/18/2011	WO2011098400A1 Igf-i poly (ethylene glycol) conjugates
08/18/2011	US20110201551 Peptide having anti-diabetic activity and use thereof
08/18/2011	US20110200569 Increasing the shelf life of bakery and patisserie products by using the antifungal lactobacillus amylovorus dsm 19280
08/18/2011	CA2786340A1 Igf-i poly (ethylene glycol) conjugates
08/17/2011	EP2357190A2 Cyclic antimicrobial peptides
08/17/2011	EP2357006A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
08/17/2011	CN102159587A Pseudoproline dipeptides
08/17/2011	CN102159285A Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors
08/17/2011	CN102153622A Immunopotentiator proline-glycocoll cyclic tetrapeptide (C14H20N404) and application
08/17/2011	CN102153621A B-cell epitope of NA-protein for new influenza A (H1N1) and application thereof
08/17/2011	CN102153620A Process for producing optically active piperazine compound
08/17/2011	CN101659691B Industrial process for producing glutamine dipeptide
08/17/2011	CN101597288B 2-aminoacyl-Beta-3-formyol tryptophan benzyl ester and preparation method and application thereof
08/16/2011	USRE42624 Methods of using macrocyclic modulators of the ghrelin receptor
08/16/2011	US7999071 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine
08/16/2011	US7998933 Process for treating the skin comprising applying to the skin at least one composition comprising at least one N-aminoacylamide
08/16/2011	US7998924 Compounds that bind to p185 and methods of using the same
08/16/2011	CA2615061C Peptide for antibody radio-labeling
08/16/2011	CA2376164C Intermolecularly associating compounds, and aggregates comprising them
08/11/2011	WO2011097633A2 Egf receptor mimicking peptides
08/11/2011	US20110195912 Oligomer-Protease Inhibitor Conjugates
08/11/2011	US20110195102 Peptides useful in the treatment and/or care of skin, mucous membranes, scalp and/or hair and their use in cosmetic or pharmaceutical compositions
08/11/2011	US20110195043 Dimeric Smac Mimetics
08/11/2011	DE102010007097A1 Konjugate aus [F-18]-Traegern mit bioaktiven, organischen Verbindungen und deren Darstellung Conjugates of [F-18] supports having bioactive organic compounds and their representation
08/10/2011	EP2353611A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
08/10/2011	EP2352394A2 Improved peptide availability
08/10/2011	EP1190074B1 Recombinant anti-cd40 antibody and uses thereof
08/09/2011	US7994362 Histone deacetylases, and uses related thereto
08/09/2011	US7994282 Card proteins involved in cell death regulation
08/09/2011	US7994279 Altered peptide ligands of GAD65
08/09/2011	US7994137 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy
08/09/2011	CA2237995C Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them
08/04/2011	WO2011094426A1 Caspase inhibitors
08/04/2011	WO2011092671A1 Proline derivatives for use in the treatment of diabetes
08/04/2011	US20110190475 Processes for removal of dibenzofulvene
08/04/2011	US20110190224 Non-Viral Delivery of Compounds to Mitochondria

1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 307